Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease

Cell Host & Microbe(2021)10.1016/j.chom.2021.06.008Source: DataRank Database

Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease is a research paper published in Cell Host & Microbe (2021). On theSindex it has a DataRank of 0. It has been cited 73 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access73 citations

Download PDF

Cite:

Linked data & code

cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 3.28)OA: bronzeTopics (84)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Rita E. Chen ORCID,Longxing Cao ORCID,Baoling Ying,Emma S. Winkler ORCID,Max Johnson ORCID

Live enrichment

PubMed:34192518 PMC:PMC8221914 OpenAlex:https://openalex.org/W3175008862

Helen Hay Whitney Foundation

Grant: T32 AI007172

Helen Hay Whitney Foundation

Grant: F30 AI152327

National Institutes of Health

Grant: Al134907

National Institutes of Health

Grant: R01 AI157155

National Institutes of Health

Grant: UL1TR001439

Defense Advanced Research Projects Agency

Grant: HR0011835403

Defense Advanced Research Projects Agency

Grant: HR001117S0019

Defense Advanced Research Projects Agency

Grant: FA8750-17-C-0219

Bill and Melinda Gates Foundation

Grant: 1156262

Bill and Melinda Gates Foundation

Grant: OPP1156262

NIAID NIH HHS

Grant: T32 AI007163

NIAID NIH HHS

Grant: R01 AI134907

National Institutes of Health

Grant: 5R01AI157155-02

Human antibody-based countermeasures against the Coronavirus SARS-CoV-2

National Institutes of Health

Grant: 5T32AI007172-37

Infectious Disease/Basic Microbial Pathogenic Mechanisms

National Institutes of Health

Grant: 1F30AI152327-01A1

Regulation of Antiviral Responses in Plasmacytoid Dendritic Cells to Chikungunya Virus by the Gut Microbiota

National Institutes of Health

Grant: 5UL1TR001439-07

UTMB Clinical and Translational Science Award

National Institutes of Health

Grant: 3R01AI134907-03S2

A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery

Amon G. Carter Foundation

Summerfield G. Roberts Foundation

Gillson Longenbaugh Foundation

John S. Dunn Foundation

Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

FWCI

3.28

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1931312821002869/pdf

publisherhttp://www.cell.com/article/S1931312821002869/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312821002869?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312821002869?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chom.2021.06.008

Fields of Study

SARS-CoV-2 and COVID-19 ResearchBacterial Infections and VaccinesInfluenza Virus Research Studies0301 basic medicine03 medical and health sciencesAdministration, IntranasalAngiotensin-Converting Enzyme 2AnimalsCOVID-19COVID-19 VaccinesDisease Models, AnimalFemaleHumansLungMaleMiceMice, Inbred C57BLPandemicsProtein BindingSARS-CoV-2Serine C-PalmitoyltransferaseSpike Glycoprotein, CoronavirusViral Load

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 VaccinesAdministration, IntranasalAnimalsDisease Models, AnimalFemaleHumansLungMaleMice, Inbred C57BLProtein BindingViral LoadSerine C-PalmitoyltransferaseMicePandemicsSpike Glycoprotein, Coronavirus

Keywords

BiologyVirologyNasal administrationDiseasePandemicInflammationLungImmune systemVirusReceptorIn vivoImmunologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Infectious disease (medical specialty)MedicineInternal medicineGeneticsMiceVariantsTherapyPathogenesisIntranasalProphylaxisReceptor-binding domainMiniproteinCovid-19Sars-cov-2MaleCOVID-19 VaccinesSerine C-PalmitoyltransferaseViral LoadArticleMice, Inbred C57BLDisease Models, AnimalSpike Glycoprotein, CoronavirusAnimalsHumansFemaleAngiotensin-Converting Enzyme 2PandemicsAdministration, IntranasalProtein Binding

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being